Identification of FOXM1 as a specific marker for triple‑negative breast cancer
Cited by 64
Related Papers
Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
|Advanced Science|2019|106
Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse glioma
|Frontiers of Medicine|2023|4